NorthMiRs is developing nanotechnology-enabled gene therapies for the treatment of sepsis. We have determined microRNAs that are dysregulated in septic patients and packaged them into a stable, synthetic, and scalable lipid nanoparticle delivery vehicle. Our lead therapeutic, NM-001, a miRNA replacement therapy for sepsis-associated cardiomyopathy has been shown to be anti-inflammatory, anti-microbial and protects organs […]

EPAID Technology: EPilepsy AI-Driven Technology aims to automate electrophysiological signal processing practice to assist clinicians in the treatment of epilepsy. We will partner with Springboard, who provides strategically positioned resources to Atlantic Canadian universities and colleges alike, helping them transfer both knowledge and technology into the private sector.

Myelofibrosis is a chronic and life-threatening blood disease. There is a need for accurate risk stratification approaches to guide personalized medicine decisions for these patients. To address this need, we developed a non-invasive blood-based test that is cost-effective, scalable and accurate. Through the Lab2Market program we will explore the market and develop the business case […]

We will assess the quality and suitability of blood and blood-derived products using a fast and economical approach that combines measurements of molecules in the blood product identified by their weight and computational approaches to make sense of all the data generated. Normal blood products have thousands of small molecules in common. By monitoring a […]

Medical devices and implants that cross the skin do not seal well with the skin, making them prone to infections and eventually failure and removal. We propose a bio-inspired coating for these devices. This coating will help these devices adhere to the skin and prevent bacteria from entering the body and causing infections. The coated […]

In Canada, heart failure (HF) has a 30-day re-admission rate of 17.6%. While patient care at home via follow-ups and self-management may reduce this rate, factors including physical fatigue and cognitive frailty delay follow-up visits and impair the patient’s ability to self-manage. An implantable solution such as CardioMEMS is available to monitor HF, however, its […]

Interstitial cystitis is a life-long condition that causes pain and pressure in the bladder. It is not clear how this condition is caused; however, we know that it involves increased bladder inflammation. Currently available treatments for interstitial cystitis do not work for everyone and often stop working after a few years. We are developing a […]

Our solution provides modular floating solar array units that aggregate into a scalable platform with energy generation capacities between 50kWh/day (0.35MWh/week) and 0.5MWh/day(3.5MWh/week), similar and compatible with the current energy needs of small and medium-size indigenous coastal communities.

Les déficiences visuelles, dues à des lésions cérébrales, touchent les nouveau-nés et les personnes âgées des pays industrialisés, en raison de l’allongement de la vie. Ce projet de recherche va utiliser la souris pour étudier la récupération des fonctions visuelles après un AVC. Il va explorer les modifications neuronales et de connectivité grâce à des […]

Infections, caused by the Candida species have emerged as a significant global health concern. These diseases can range from superficial to life-threatening, affecting various body parts. However, the effective management of Candida infections is increasingly challenged by the growing issue of drug resistance.Focusing on that problem, our research project aims to investigate the antifungal properties […]

One key stumbling block to the success of health care systems has been their adoption and use by health care. This study will employ the Unified Theory of Acceptance and Use of Technology (UTAUT) as the basis for determining what predicts health care professionals’ acceptance and perceived effective use of Oculys’ DSS. It is the […]

BIOVECTRA is a North American CDMO focusing on optimizing, adapting, and perfecting innovative technologies and drug substance development to deliver effective and novel solutions for pharmaceutical manufacturing. Challenges and opportunities include: • Solving complex therapeutic challenges in collaboration with partners through contract development and manufacturing • Offering products and services of exceptional caliber, on time […]